• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国镰状细胞病的新生儿筛查:对20年数据的回顾

Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades.

作者信息

Therrell Bradford L, Lloyd-Puryear Michele A, Eckman James R, Mann Marie Y

机构信息

Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229; National Newborn Screening and Global Resource Center (NNSGRC), 39 07 Galacia Dr, Austin, TX 78759.

American College of Medical Genetics and Genomics, Bethesda, MD 20814.

出版信息

Semin Perinatol. 2015 Apr;39(3):238-51. doi: 10.1053/j.semperi.2015.03.008.

DOI:10.1053/j.semperi.2015.03.008
PMID:25979783
Abstract

UNLABELLED

Sickle cell disease is a group of disorders, the majority of which are detected through state newborn screening programs. There is limited knowledge of disease prevalence in the U.S.

POPULATION

We report 20 years of case finding and laboratory data for sickle cell disease and trait to assist in: planning for health services delivery; providing data for researchers; aiding in tracking health outcome trends; and assessing sickle gene prevalence in the newborn population. During the 20-year period, there were 39,422 confirmed cases of sickle cell disease among 76,527,627 newborn births screened (1:1941) and 1,107,875 laboratory reports of probable sickle trait among 73,951,175 newborn births screened (1:67). The highest sickle cell disease incidence during the 20 years was in the District of Columbia (1:437) followed by Mississippi (1:683) and South Carolina (1:771). For sickle cell trait, the highest incidences were in the District of Columbia (1:22), Mississippi (1:26), and South Carolina (1:31).

摘要

未标注

镰状细胞病是一组疾病,其中大多数是通过州新生儿筛查项目检测出来的。在美国,对该病的患病率了解有限。

研究对象

我们报告了20年镰状细胞病及其特征的病例发现和实验室数据,以协助进行以下工作:规划医疗服务提供;为研究人员提供数据;帮助追踪健康结果趋势;以及评估新生儿群体中镰状基因的患病率。在这20年期间,在76,527,627例接受筛查的新生儿中,有39,422例确诊为镰状细胞病(1:1941),在73,951,175例接受筛查的新生儿中,有1,107,875份实验室报告显示可能存在镰状特征(1:67)。20年期间镰状细胞病发病率最高的是哥伦比亚特区(1:437),其次是密西西比州(1:683)和南卡罗来纳州(1:771)。对于镰状特征,发病率最高的是哥伦比亚特区(1:22)、密西西比州(1:26)和南卡罗来纳州(1:31)。

相似文献

1
Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades.美国镰状细胞病的新生儿筛查:对20年数据的回顾
Semin Perinatol. 2015 Apr;39(3):238-51. doi: 10.1053/j.semperi.2015.03.008.
2
Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.镰状细胞病和镰状细胞性状新生儿筛查阳性结果的传达:各州之间的差异
Am J Med Genet C Semin Med Genet. 2008 Feb 15;148C(1):15-22. doi: 10.1002/ajmg.c.30160.
3
History and current status of newborn screening for hemoglobinopathies.血红蛋白病新生儿筛查的历史和现状。
Semin Perinatol. 2010 Apr;34(2):134-44. doi: 10.1053/j.semperi.2009.12.006.
4
Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.阿拉伯联合酋长国通过新生儿筛查检测出的血红蛋白病发病率。
East Mediterr Health J. 2005 May;11(3):300-7.
5
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.德国西南部镰状细胞病的显著流行:一项出生队列研究结果表明新生儿筛查的必要性。
Ann Hematol. 2016 Feb;95(3):397-402. doi: 10.1007/s00277-015-2573-y. Epub 2015 Dec 12.
6
Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.乌干达共和国 2014-2019 年镰状细胞特征和疾病筛查趋势。
Trop Med Int Health. 2021 Jan;26(1):23-32. doi: 10.1111/tmi.13506. Epub 2020 Dec 14.
7
Assisted reproductive technology surveillance--United States, 2011.辅助生殖技术监测——美国,2011 年。
MMWR Surveill Summ. 2014 Nov 21;63(10):1-28.
8
Sickle cell in Latin America and the United States [corrected].镰状细胞在拉丁美洲和美国[已纠正]。
Pediatr Blood Cancer. 2015 Jul;62(7):1131-6. doi: 10.1002/pbc.25450. Epub 2015 Mar 2.
9
[Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].[镰状细胞贫血的新生儿靶向筛查:西非地区产前评估中的镰变试验(埃默尔试验)界限]
Rev Epidemiol Sante Publique. 2018 May;66(3):181-185. doi: 10.1016/j.respe.2018.02.007. Epub 2018 Apr 4.
10
Genetic Blood Disorders Survey in the Sultanate of Oman.阿曼苏丹国的遗传性血液疾病调查。
J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.

引用本文的文献

1
Racial Inequities Influencing Admission, Disposition and Hospital Outcomes for Sickle Cell Anemia Patients: Insights from the National Inpatient Sample Database.影响镰状细胞贫血患者入院、处置及医院结局的种族不平等:来自国家住院样本数据库的见解
Hematol Rep. 2025 May 9;17(3):27. doi: 10.3390/hematolrep17030027.
2
Hematology training in Africa: from brain drain to brain gain.非洲的血液学培训:从人才流失到人才流入。
Blood Adv. 2025 Feb 25;9(4):948-949. doi: 10.1182/bloodadvances.2024015253.
3
Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait.
在新生儿血红蛋白病筛查中增加分子遗传学检测以确诊α地中海贫血特征的临床效用。
Int J Neonatal Screen. 2025 Feb 7;11(1):12. doi: 10.3390/ijns11010012.
4
Comprehensive Neonatal Screening for Genetic Disorders in Tribal Populations of Central India.印度中部部落人群遗传性疾病的新生儿综合筛查
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S4021-S4025. doi: 10.4103/jpbs.jpbs_1398_24. Epub 2024 Nov 30.
5
Variability in Notification of Positive Newborn Screening Results for Sickle Cell Trait Across the United States.美国各地镰状细胞性状新生儿筛查阳性结果通知的差异。
Adv Hematol. 2024 Dec 19;2024:3854629. doi: 10.1155/ah/3854629. eCollection 2024.
6
Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events.2015年至2022年加泰罗尼亚地区镰状细胞病的新生儿筛查——流行病学及对临床事件的影响
Int J Neonatal Screen. 2024 Oct 3;10(4):69. doi: 10.3390/ijns10040069.
7
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.参与PIVOT(撒哈拉以南非洲地区针对HbSC疾病开展的羟基脲随机临床试验)的加纳儿童和成人的基线特征。
Br J Haematol. 2024 Dec;205(6):2470-2480. doi: 10.1111/bjh.19832. Epub 2024 Oct 15.
8
Fostering a healthier generation of children with sickle cell disease through advancements in care.通过护理方面的进步,培养出更健康的镰状细胞病患儿一代。
Pediatr Res. 2024 Sep 13. doi: 10.1038/s41390-024-03566-w.
9
Impact of hydroxyurea on follicle density in patients with sickle cell disease.羟基脲对镰状细胞病患者卵泡密度的影响。
Blood Adv. 2024 Oct 8;8(19):5227-5235. doi: 10.1182/bloodadvances.2023011536.
10
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).《2024年全球新生儿血斑筛查现状:2020 - 2023年近期活动综合回顾》
Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038.